Management of muscle invasive bladder cancer / Sanchia S. Goonewardene, Karen Ventii, Amit Bahl, Raj Persad, Hanif Motiwala, David Albala.

This book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer pr...

Full description

Saved in:
Bibliographic Details
Main Author: Goonewardene, Sanchia
Other Authors: Ventii, Karen, Bahl, Amit, Persad, Raj, Motiwala, Hanif, Albala, David
Format: eBook
Language:English
Published: Cham : Springer, 2021.
Series:Management of Urology.
Subjects:
Online Access:Click for online access
Table of Contents:
  • 1. Introduction to muscle invasive bladder cancer
  • 2. Epidemiology and risk factors in muscle invasive bladder cancer
  • 3. The molecular basis of muscle invasive bladder cancer
  • 4. Histological variants in MIBC
  • squamous cell and squamous differentiation
  • 5. Histological variants in muscle invasive bladder cancer
  • adenocarcinoma
  • 6. Histological variants in muscle invasive bladder Cancer
  • sarcomatoid cancer
  • 7. MIBC Carcinosarcoma
  • 8. Muscle invasive bladder cancer- small cell
  • 9. MIBC plasmacytoid
  • 10. MIBC and micropapillary bladder cancer
  • 11. MIBC bladder cancer assessment and diagnosis
  • 12. A systematic review on blue light cystoscopy in bladder cancer diagnostics
  • 13. A systematic review on the staging conundrum in bladder cancer
  • 14. Current state of investigations and limitations in muscle invasive bladder cancer
  • 15. Risk stratification in bladder cancer
  • 16. Preventative measures for those with high risk MIBC
  • 17. Bladder cancer risk post pelvic irradiation
  • 18. A systematic review on bladder preservation strategies and MIBC
  • 19. Partial cystectomy
  • 20. Muscle invasive bladder cancer and neoadjuvant chemotherapy
  • 21. Controversies in clinical effectiveness of neoadjuvant chemotherapy
  • 22. Trimodal therapy in bladder cancer
  • 23. Systematic review on trimodal therapy in bladder cancer
  • 24. Trimodal therapy
  • a systematic review
  • 25. Reviews related to trimodal therapy for MIBC
  • 26. Radical cystectomy lap open robotic
  • 27. Prostate sparing cystectomy
  • a systematic review
  • 28. A systematic review on nerve sparing cystoprostatectomy
  • 29. MIBC
  • orthotopic vs ileal conduit
  • 30. MIBC
  • a systematic review on orthotopic neobladder vs. ileal conduit
  • 31. MIBC and radical cystectomy in the elderly
  • 32. MIBC radical radiotherapy
  • 33. MIBC
  • quality of life with urinary diversion
  • 34. Neoadjuvant chemotherapy for muscle invasive bladder cancer
  • 35. Muscle invasive bladder cancer and the staging conundrum
  • 36. Radical cystectomy outcomes
  • 37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy
  • 38. Muscle invasive bladder cancer and the staging conundrum
  • 39. Physical pre-habilitation prior to radical cystectomy
  • 40. Exercise therapy pre surgery
  • 41. Patient fitness for surgery
  • 42. CPEX testing prior to major urological surgery
  • 43. Cardio-pulmonary exercise testing and major urological surgery
  • 44. Robotic radical cystectomy and enhanced recovery
  • 45. The robotic approach to redo surgery
  • 46. Robotic cystectomy and intracorporeal neobladder formation
  • 47. Secondary pelvic malignancies and bladder cancer
  • 48. Organ sparing cystectomy
  • 49. Robotic radical cystectomy
  • 50. Robotic cystectomy and intracorporeal stoma formation
  • 51. Orthotopic neobladders vs. ileal conduits
  • 52. The role of enhanced recovery in robotic cystectomy
  • 53. Robotic radical cystectomy and lymph node dissection
  • 54. Robotic cystectomy and sentinel node mapping
  • 55. Robotic radical cystectomy and intracorporeal stoma formation
  • 56. Lap vs open vs robotic cystectomy
  • 57. A systematic review on obesity in bladder cancer
  • 58. Systematic review results on obesity in bladder cancer
  • 59. Reviews on BMI and bladder cancer
  • 60. Survivorship Issues in muscle invasive bladder cancer
  • 61. Muscle invasive bladder cancer and health related quality of life
  • 62. Body image in bladder cancer
  • 63. The rationale for neoadjuvant chemotherapy
  • 64. Support for partners in bladder cancer.